Tag: PTSD

Posted on

Pre-Pilot WINGS+++: mHealth to Improve MOUD Uptake in Women Experiencing Intimate Partner Violence and PTSD

Conditions: Opioid-Related Disorders; Substance-Related Disorders; Intimate Partner Violence (IPV); Stress Disorders, Post-Traumatic; Domestic Violence; Medication for Opioid Use Disorder (MOUD); Post Traumatic Stress Disorder PTSD

Interventions: Behavioral: Pre-Pilot WINGS++++

Sponsors: Dawn A. Goddard-Eckrich; National Institute on Drug Abuse (NIDA); City University of New York; University of Pennsylvania

Not yet recruiting
Posted on

Early Intervention to Prevent Development of PTSD in Burn Survivors and Their Caregivers

Conditions: Posttraumatic Stress Disorder; Burns; Traumatic Injury; Acute Stress Disorder; Trauma and Stressor Related Disorders; Trauma and Stress Related Disorders; Stress Disorder; Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic; Stress Disorders, Traumatic, Acute; Relationship, Social

Interventions: Behavioral: Promotion of Emotional Disclosure for Burns (PoED-B); Behavioral: minimally Enhanced Usual Care control (mEUC)

Sponsors: University of Southern California; Los Angeles General Medical Center; National Institute of Mental Health (NIMH)

Not yet recruiting
Posted on
<![CDATA[New SLEEP 2026 insights reveal how REM sleep preserves memories while stripping emotional sting—key clues for PTSD and healthier sleep.]]>
Posted on

Sexual function in women with complex PTSD: a comparative study

BackgroundPosttraumatic stress disorder (PTSD) is associated with impaired sexual functioning in women, but the effects of complex PTSD (CPTSD) remain unclear. This study tested three hypotheses: (1) women with CPTSD would report lower overall sexual function than women with PTSD and trauma-exposed controls; (2) the pain domain would show the largest group differences; and (3) CPTSD symptom severity would be negatively associated with sexual function, while PTSD symptom severity would not.MethodsA cross-sectional study included 386 Mexican female university students (18–55 years) who completed the Female Sexual Function Index (FSFI), International Trauma Questionnaire (ITQ), and Adverse Childhood Experiences Questionnaire (ACE-IQ). Group differences were assessed using ANOVA with post-hoc comparisons. Multivariable linear regressions examined whether CPTSD severity predicted sexual function independently of PTSD severity and age. A sensitivity analysis excluded women aged 45 and older.ResultsFSFI total scores differed significantly across groups (F = 3.52, p = 0.031). Women with CPTSD reported lower overall sexual function (M = 26.56, SD = 6.41) than trauma-exposed controls (M = 28.86, SD = 5.03; p = 0.047). In the pain domain, women with CPTSD reported greater sexual pain than controls (F = 6.35, p = 0.002). Multivariable regressions showed that CPTSD severity predicted lower FSFI total scores (β = -0.22, p < 0.001), independent of age and PTSD severity (adjusted R2 = 0.028). For sexual pain, the bivariate association with CPTSD (rho = -0.16, p < 0.01) did not persist after adjusting for age; age was the only significant predictor (β = 0.02, p = 0.007). Sensitivity analyses yielded unchanged results.ConclusionsCPTSD severity is associated with poorer overall sexual function, independent of age and PTSD severity. However, the association with sexual pain did not persist after accounting for age. Clinical and research implications are discussed.
Posted on

Posttraumatic Stress Disorder Treatment Decision Aid: User-Centered Design Update Approach

<strong>Background:</strong> Posttraumatic stress disorder (PTSD) is associated with significant health and societal economic burdens, making treatment a priority. There are effective treatments, but there is no indication at this point which treatments will work best for which patients. Patient decision aids (DAs) are evidence-based tools designed to support patients and providers in weighing the benefits and risks of different treatment options and in making value-informed choices as one part of shared decision-making. The National Center for PTSD published an online PTSD Treatment DA in 2017. <strong>Objective:</strong> This paper outlines a collaborative process for significantly updating the PTSD Treatment DA in line with newer clinical practice guidelines and updated technological needs. <strong>Methods:</strong> The development and updating process was conducted by a small team in consultation with an expert panel and consumer input. User experience testing with people who screened positive for PTSD focused on the experience of completing specific core tasks such as comparing treatment options using the DA. Field testing included Veterans Administration patients and providers using the DA in clinical appointments to gather feedback about feasibility, satisfaction, acceptability, balance, fidelity, decisional conflict, and decisional self-efficacy. <strong>Results:</strong> Pilot field testing suggested that the PTSD Treatment DA was acceptable, satisfactory, balanced, feasible to implement, and associated with improvements in decisional conflict and in decisional self-efficacy in this small sample. Design decisions based on stakeholder feedback are described, including which treatments to include, what design format to use, how to assess preferences, and how to most effectively convey treatment effectiveness information. <strong>Conclusions:</strong> The revised PTSD Treatment Decision Aid is freely available online and is consistent with the International Patient Decision Aid Standards.